Logo image of OPRX

OPTIMIZERX CORP (OPRX) Stock Fundamental Analysis

NASDAQ:OPRX - Nasdaq - US68401U2042 - Common Stock - Currency: USD

5.78  -0.41 (-6.62%)

After market: 5.78 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OPRX. OPRX was compared to 39 industry peers in the Health Care Technology industry. While OPRX seems to be doing ok healthwise, there are quite some concerns on its profitability. OPRX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OPRX had positive earnings in the past year.
OPRX had a negative operating cash flow in the past year.
OPRX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPRX reported negative operating cash flow in multiple years.
OPRX Yearly Net Income VS EBIT VS OCF VS FCFOPRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M -15M

1.2 Ratios

With a decent Return On Assets value of -14.63%, OPRX is doing good in the industry, outperforming 67.57% of the companies in the same industry.
The Return On Equity of OPRX (-21.12%) is better than 70.27% of its industry peers.
Industry RankSector Rank
ROA -14.63%
ROE -21.12%
ROIC N/A
ROA(3y)-5.93%
ROA(5y)-5.4%
ROE(3y)-7.55%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
OPRX Yearly ROA, ROE, ROICOPRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

OPRX's Gross Margin of 62.60% is in line compared to the rest of the industry. OPRX outperforms 54.05% of its industry peers.
OPRX's Gross Margin has been stable in the last couple of years.
OPRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y0.83%
OPRX Yearly Profit, Operating, Gross MarginsOPRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

OPRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPRX has more shares outstanding
OPRX has more shares outstanding than it did 5 years ago.
OPRX has a worse debt/assets ratio than last year.
OPRX Yearly Shares OutstandingOPRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
OPRX Yearly Total Debt VS Total AssetsOPRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that OPRX is in the distress zone and has some risk of bankruptcy.
OPRX has a Altman-Z score of 1.08. This is comparable to the rest of the industry: OPRX outperforms 54.05% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that OPRX is not too dependend on debt financing.
OPRX has a Debt to Equity ratio (0.29) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC10.14%
OPRX Yearly LT Debt VS Equity VS FCFOPRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

OPRX has a Current Ratio of 3.23. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.23, OPRX is doing good in the industry, outperforming 75.68% of the companies in the same industry.
OPRX has a Quick Ratio of 3.23. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
OPRX has a better Quick ratio (3.23) than 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 3.23
OPRX Yearly Current Assets VS Current LiabilitesOPRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.83% over the past year.
The Earnings Per Share has been growing by 9.58% on average over the past years. This is quite good.
Looking at the last year, OPRX shows a very strong growth in Revenue. The Revenue has grown by 40.41%.
Measured over the past years, OPRX shows a very strong growth in Revenue. The Revenue has been growing by 27.52% on average per year.
EPS 1Y (TTM)20.83%
EPS 3Y9.58%
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)40.41%
Revenue growth 3Y18.2%
Revenue growth 5Y27.52%
Sales Q2Q%30.48%

3.2 Future

Based on estimates for the next years, OPRX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.11% on average per year.
The Revenue is expected to grow by 15.61% on average over the next years. This is quite good.
EPS Next Y25.97%
EPS Next 2Y18.21%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue Next Year27.91%
Revenue Next 2Y18.9%
Revenue Next 3Y15.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPRX Yearly Revenue VS EstimatesOPRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
OPRX Yearly EPS VS EstimatesOPRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

OPRX is valuated rather expensively with a Price/Earnings ratio of 19.93.
OPRX's Price/Earnings ratio is rather cheap when compared to the industry. OPRX is cheaper than 91.89% of the companies in the same industry.
OPRX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.62.
A Price/Forward Earnings ratio of 16.55 indicates a correct valuation of OPRX.
Based on the Price/Forward Earnings ratio, OPRX is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
OPRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.93
Fwd PE 16.55
OPRX Price Earnings VS Forward Price EarningsOPRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPRX Per share dataOPRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

OPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OPRX's earnings are expected to grow with 25.11% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y18.21%
EPS Next 3Y25.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTIMIZERX CORP

NASDAQ:OPRX (2/21/2025, 8:00:02 PM)

After market: 5.78 0 (0%)

5.78

-0.41 (-6.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners68.35%
Inst Owner Change-88.17%
Ins Owners10.62%
Ins Owner Change3.31%
Market Cap106.47M
Analysts81.43
Price Target9.84 (70.24%)
Short Float %8.16%
Short Ratio5.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)110.68%
Min EPS beat(2)90.65%
Max EPS beat(2)130.72%
EPS beat(4)3
Avg EPS beat(4)53.92%
Min EPS beat(4)-21.08%
Max EPS beat(4)130.72%
EPS beat(8)6
Avg EPS beat(8)64.26%
EPS beat(12)9
Avg EPS beat(12)47.25%
EPS beat(16)12
Avg EPS beat(16)52.43%
Revenue beat(2)0
Avg Revenue beat(2)-12.55%
Min Revenue beat(2)-16.43%
Max Revenue beat(2)-8.68%
Revenue beat(4)2
Avg Revenue beat(4)-4.13%
Min Revenue beat(4)-16.43%
Max Revenue beat(4)6.46%
Revenue beat(8)4
Avg Revenue beat(8)-3.46%
Revenue beat(12)4
Avg Revenue beat(12)-4.18%
Revenue beat(16)8
Avg Revenue beat(16)-2.01%
PT rev (1m)-13.65%
PT rev (3m)-6.25%
EPS NQ rev (1m)8.55%
EPS NQ rev (3m)-10.39%
EPS NY rev (1m)9.15%
EPS NY rev (3m)-12.86%
Revenue NQ rev (1m)2.77%
Revenue NQ rev (3m)2.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.46%
Valuation
Industry RankSector Rank
PE 19.93
Fwd PE 16.55
P/S 1.21
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.29
EY5.02%
EPS(NY)0.35
Fwd EY6.04%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS4.79
BVpS6.21
TBVpS-0.16
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.63%
ROE -21.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.6%
FCFM N/A
ROA(3y)-5.93%
ROA(5y)-5.4%
ROE(3y)-7.55%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y0.83%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.59%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.23
Quick Ratio 3.23
Altman-Z 1.08
F-Score3
WACC10.14%
ROIC/WACCN/A
Cap/Depr(3y)23.84%
Cap/Depr(5y)42.47%
Cap/Sales(3y)0.78%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.83%
EPS 3Y9.58%
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y25.97%
EPS Next 2Y18.21%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue 1Y (TTM)40.41%
Revenue growth 3Y18.2%
Revenue growth 5Y27.52%
Sales Q2Q%30.48%
Revenue Next Year27.91%
Revenue Next 2Y18.9%
Revenue Next 3Y15.61%
Revenue Next 5YN/A
EBIT growth 1Y27.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year199.59%
EBIT Next 3Y51.93%
EBIT Next 5YN/A
FCF growth 1Y-118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.05%
OCF growth 3YN/A
OCF growth 5YN/A